Status:
COMPLETED
ASPIRE II. Supporting Antibiotic Stewardship in Primary Care Via POCT
Lead Sponsor:
University of South Wales
Collaborating Sponsors:
Cwm Taf University Health Board (NHS)
Conditions:
Acute Respiratory Infection
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Acute Respiratory Infections (ARIs) are a major contributor to antibiotic resistance, largely due to the over prescription of antibiotics driven by the subjective nature of clinical assessment. The AS...
Detailed Description
In the first ASPIRE study, in which the POC test was taken after the consultation, 20 participants produced results in the ratio 10:7:3 (negative, bacterial, viral) with a 75% agreement to the antibio...
Eligibility Criteria
Inclusion
- Subject \>18 years of age.
- having new onset symptoms suggestive of acute respiratory infection (ARI within 7 days of seeking care: runny nose, nasal congestion, sore throat, cough, hoarse voice, shortness of breath) with or without fever.
Exclusion
- Unable to provide informed consent.
- Undergoing end of life care.
- Immunocompromised or taking chemotherapy, oral steroids, or interferon.
- Receiving a live vaccine in the last 14 days.
- Taking antibiotics or antivirals in the last 14 days.
- Patients that have symptoms lasting more than 7 days.
Key Trial Info
Start Date :
April 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2024
Estimated Enrollment :
144 Patients enrolled
Trial Details
Trial ID
NCT06981130
Start Date
April 1 2023
End Date
December 1 2024
Last Update
May 20 2025
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Kier Hardie Practice 3
Merthyr Tydfil, Rhondda Cynon Taff, United Kingdom
2
Oaktree Surgery
Bridgend, United Kingdom
3
Meddygfa Glan Cynon Surgery
Mountain Ash, United Kingdom